Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Recent updates on molecular genetic engineering approaches and applications of human therapeutic proteins.
Pain, cognition and quality of life associate with structural measures of brain volume loss in multiple sclerosis.
Neuromuscular Diseases.
Clinical Application of Autologous Adipose Stem Cells in Patients with Multiple Sclerosis: Preliminary Results.
Weston-Hurst syndrome: a rare fulminant form of acute disseminated encephalomyelitis (ADEM).
The role of α4 integrin in Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease: an infectious animal model for multiple sclerosis (MS).
Autoimmunity meets genetics: Multiple sclerosis in a patient with Kallmann syndrome.
Identification of gene expression patterns critically involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
Etiological, clinical, and radiological features of longitudinally extensive myelopathy in Chinese patients.
The epigenome in Alzheimer's disease: current state and approaches for a new path to gene discovery and understanding disease mechanism.
Rethinking the importance of paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis: They do matter.
Heat Shock Proteins: Old and Novel Roles in Neurodegenerative Diseases in the Central Nervous System.
The "butterfly diagram": A gait marker for neurological and cerebellar impairment in people with multiple sclerosis.
Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis.
Symptomatic Management of Multiple Sclerosis-Associated Tremor Among Participants in the NARCOMS Registry.
Age-related myelin degradation burdens the clearance function of microglia during aging.
Cerebral blood flow modulation insufficiency in brain networks in multiple sclerosis: A hypercapnia MRI study.
Neuromuscular Electrical Stimulation Can Improve Walking Endurance In Individuals With Multiple Sclerosis: 2573 Board #96 June 3, 9: 30 AM - 11: 00 AM.
Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis.
Evaluation of a Fatigue Self-Management Program for People with Multiple Sclerosis.
Description of the Characteristics of Multiple Sclerosis Patients in the Region of Valencia (Spain) Who Requested Treatment with Disease-Modifying Drugs during the 2005-2014 Decade.
Relationship between the corpus callosum and neurocognitive disabilities in children with NF-1: diffusion tensor imaging features.
The Myelinogenesis Process in Undernourished Rats Rehabilitated with Different Dietary Lipids.
Iron uptake and transport across physiological barriers.
Somatodendritic Expression of JAM2 Inhibits Oligodendrocyte Myelination.
Pages
« first
‹ previous
…
831
832
833
834
835
836
837
838
839
…
next ›
last »